Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Long-Term Debt Issuances (2016 - 2025)

Marimed has reported Long-Term Debt Issuances over the past 11 years, most recently at $2.0 million for Q2 2025.

  • Quarterly Long-Term Debt Issuances changed N/A to $2.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, up 71.97% year-over-year, with the annual reading at $2.0 million for FY2025, 71.97% up from the prior year.
  • Long-Term Debt Issuances was $2.0 million for Q2 2025 at Marimed, up from $1.2 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $29.1 million in Q4 2023 and troughed at $1.2 million in Q1 2024.
  • The 4-year median for Long-Term Debt Issuances is $2.3 million (2021), against an average of $8.7 million.
  • The largest YoY upside for Long-Term Debt Issuances was 38.63% in 2021 against a maximum downside of 38.63% in 2021.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $2.7 million in 2021, then surged by 991.93% to $29.1 million in 2023, then plummeted by 96.0% to $1.2 million in 2024, then surged by 71.97% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Long-Term Debt Issuances are $2.0 million (Q2 2025), $1.2 million (Q1 2024), and $29.1 million (Q4 2023).